Latest Articles

Publication Date
INTERACT Supports Updated NCCN Guidelines that Expand Access to Appropriate Hereditary Cancer Genetic Testing for Patients with Colorectal, Endometrial, and Gastric Cancers - Longview News-Journal

INTERACT Supports Updated NCCN Guidelines that Expand Access to Appropriate Hereditary Cancer Genetic Testing for Patients with Colorectal, Endometrial, and Gastric Cancers Longview News-Journal

Published: Oct. 17, 2024, 1 p.m.
How AI is Helping Researchers Find High-Risk Cancers - TheTyee.ca

How AI is Helping Researchers Find High-Risk Cancers TheTyee.ca

Published: July 17, 2024, 7 a.m.
New study finds popular weight-loss and diabetes medications may be linked to lower risk of some cancers - ABC7 Bay Area

New study finds popular weight-loss and diabetes medications may be linked to lower risk of some cancers ABC7 Bay Area

Published: July 8, 2024, 7 a.m.
AI-based histopathology image analysis reveals a distinct subset of endometrial cancers - Nature.com

AI-based histopathology image analysis reveals a distinct subset of endometrial cancers Nature.com

Published: June 26, 2024, 7 a.m.
Endometriosis increases risks for ovarian, endometrial cancers - Healio

Endometriosis increases risks for ovarian, endometrial cancers Healio

Published: June 7, 2024, 7 a.m.
ASCO Reading Room | Sound Evidence to Treat Smaller, Recurrent Endometrial Cancers With Radiotherapy Alone - Medpage Today

ASCO Reading Room | Sound Evidence to Treat Smaller, Recurrent Endometrial Cancers With Radiotherapy Alone Medpage Today

Published: June 5, 2024, 7 a.m.
For some endometriosis-related ovarian cancers, timing is everything - Medical Xpress

For some endometriosis-related ovarian cancers, timing is everything Medical Xpress

Published: May 28, 2024, 7 a.m.
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses - Nature.com

Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses Nature.com

Published: April 23, 2024, 7 a.m.
Genetically identification of endometriosis and cancers risk in women through a two-sample Mendelian randomization study | Scientific Reports - Nature.com

Genetically identification of endometriosis and cancers risk in women through a two-sample Mendelian randomization study | Scientific Reports Nature.com

Published: April 10, 2024, 7 a.m.
The prognostic value of MEK pathway–associated estrogen receptor signaling activity for female cancers - Nature.com

The prognostic value of MEK pathway–associated estrogen receptor signaling activity for female cancers Nature.com

Published: April 6, 2024, 7 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!